1)牛久哲男.病理診断に直結した組織学─食道.病理と臨 35(臨増):179-188, 2017
2)大橋健一.各臓器,疾患で用いられる抗体とその応用─食道.病理と臨 25(臨増):34-41, 2007
3)Kobayashi M, Kawachi H, Takizawa T, et al. p53 Mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection. Oncology 71:237-245, 2006
4)Ohashi K, Horiguchi S, Moriyama S, et al. Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract 199:713-721, 2003
5)Arai T, Aida J, Nakamura K, et al. Clinicopathologic characteristics of basaloid squamous carcinoma of the esophagus. Esophagus 8:169-177, 2011
6)Arai T, Yanagisawa A, Kondo F, et al. Clinicopathologic characteristics of esophageal primary malignant melanoma. Esophagus 13:17-24, 2016
7)立石陽子,大橋健一.腫瘍の鑑別に用いられる抗体(各臓器別)食道.病理と臨 32(臨増):102-108, 2014
8)Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 30:288-294, 1999
9)Ormsby AH, Goldblum JR, Rice TW, et al. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 38:307-311, 2001
10)Taniere P, Borghi-Scoazec G, Saurin JC, et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol 26:1213-1221, 2002
11)新井冨生,松田陽子,濱保英樹,他.食道胃接合部腺癌の病理学的特徴.胃と腸 50:1109-1117, 2015
12)日本食道学会(編).食道癌取扱い規約,第11版.金原出版,2015